Mariner’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-28,760
Closed -$69.6K 3668
2025
Q2
$69.6K Hold
28,760
﹤0.01% 3296
2025
Q1
$23.7K Hold
28,760
﹤0.01% 3366
2024
Q4
$24.4K Sell
28,760
-2,775
-9% -$3.09K ﹤0.01% 3342
2024
Q3
$39.1K Hold
31,535
﹤0.01% 3215
2024
Q2
$52.7K Hold
31,535
﹤0.01% 3049
2024
Q1
$58.7K Buy
31,535
+17,937
+132% +$33.1K ﹤0.01% 3007
2023
Q4
$25.8K Buy
+13,598
New +$20.3K ﹤0.01% 2986
2023
Q1
Sell
-12,459
Closed -$52K 2834
2022
Q4
$52K Buy
+12,459
New +$47.2K ﹤0.01% 2608

Other funds holding NBP

Mariner's NBP Position: Q3 2025 in Review

Mariner sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2025, closing a stake of 28,760 shares — an estimated $69.6K sold.

Mariner first reported a position in NBP in Q4 2022 and held it in 8 quarters. The position peaked at $69.6K in Q2 2025. 42 funds tracked by Wall St. Rank hold NBP as of Q3 2025.

  • Mariner reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2025 after selling out during the quarter.
  • Mariner sold 28,760 NovaBridge Biosciences American Depositary Shares shares in Q3 2025, an estimated $69.6K.
  • Mariner first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2022 and held it in 8 quarters.
  • Mariner's NovaBridge Biosciences American Depositary Shares position peaked at $69.6K in Q2 2025.
  • 42 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2025.

Based on Mariner's 13F filing for Q3 2025, filed 14 Nov 2025.